Negócios · 16/04/20041 min de leitura
Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.